Showing results (31-40 of 111) with videos related to
Sort By:
Pageof 12
Plos One|November 14, 2013
Branched-chain amino acids enhance premature senescence through mammalian target of rapamycin complex I-mediated upregulation of p21 proteinMasayuki Nakano, Akio Nakashima, Taiki Nagano, et al.Biochemical and Biophysical Research Communications|December 15, 2015
Versatile function of the circadian protein CIPC as a regulator of Erk activationRyota Matsunaga, Tasuku Nishino, Atsushi Yokoyama, et al.Journal of Cell Science|September 15, 2012
Psk1, an AGC kinase family member in fission yeast, is directly phosphorylated and controlled by TORC1 and functions as S6 kinaseAkio Nakashima, Yoko Otsubo, Akira Yamashita, et al.Journal of Bone and Mineral Metabolism|March 21, 2024
Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysisKazuhiko Kato, Tatsuhiro Yaginuma, Arisa Kobayashi, et al.Cell Cycle (Georgetown, Tex.)|August 3, 2013
Cyclin I is involved in the regulation of cell cycle progressionTaiki Nagano, Toshiaki Hashimoto, Akio Nakashima, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 12, 2024
Association Between Parathyroid Hormone-Related Peptide Levels and Mortality in Patients With MalignancyAi Kimura, Kazuhiko Kato, Akio Nakashima, et al.Clinical and Experimental Nephrology|July 2, 2024
Association between serum magnesium levels and cognitive function in patients undergoing hemodialysisKazuhiko Kato, Akio Nakashima, Shunichiro Shinagawa, et al.JBMR Plus|February 10, 2025
Parathyroid hormone-related protein levels and treatment outcomes in hypercalcemia of malignancy: a retrospective cohort studyKazuhiko Kato, Akio Nakashima, Ai Kimura, et al.Journal of Clinical Medicine|December 23, 2023
Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational StudyKou Masaki, Motoyasu Miyazaki, Hideki Kakimoto, et al.FEBS Letters|December 16, 2014
Tumor necrosis factor-α reduces beta-amyloid accumulation primarily by lowering cellular prion protein levels in a brain endothelial cell lineYuki Yasutaka, Takuya Watanabe, Akio Nakashima, et al.Pageof 12